Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of Tr34/L98h- and Tr46/Y121f/T289a-Positive Aspergillus Fumigatus Isolates Obtained From Patients in Iran From 2010 to 2014 Publisher Pubmed



Mohammadi F1 ; Hashemi SJ1 ; Zoll J2 ; Melchers WJG2 ; Rafati H3 ; Dehghan P4 ; Rezaie S1 ; Tolooe A5 ; Tamadon Y5 ; Van Der Lee HA2 ; Verweij PE2 ; Seyedmousavi S2, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Mycology and Parasitology, School of Hygiene, Institute of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands
  3. 3. Department of Biochemistry, Erasmus University Medical Center, Rotterdam, Netherlands
  4. 4. Department of Medical Mycology and Parasitology, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  6. 6. Invasive Fungi Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  7. 7. Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands

Source: Antimicrobial Agents and Chemotherapy Published:2016


Abstract

We employed an endpoint genotyping method to update the prevalence rate of positivity for the TR34/L98H mutation (a 34-bp tandem repeat mutation in the promoter region of the cyp51A gene in combination with a substitution at codon L98) and the TR46/Y121F/T289A mutation (a 46-bp tandem repeat mutation in the promoter region of the cyp51A gene in combination with substitutions at codons Y121 and T289) among clinical Aspergillus fumigatus isolates obtained from different regions of Iran over a recent 5-year period (2010 to 2014). The antifungal activities of itraconazole, voriconazole, and posaconazole against 172 clinical A. fumigatus isolates were investigated using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution method. For the isolates with an azole resistance phenotype, the cyp51A gene and its promoter were amplified and sequenced. In addition, using a LightCycler 480 real-time PCR system, a novel endpoint genotyping analysis method targeting single-nucleotide polymorphisms was evaluated to detect the L98H and Y121F mutations in the cyp51A gene of all isolates. Of the 172 A. fumigatus isolates tested, the MIC values of itraconazole (≥16 mg/liter) and voriconazole (>4 mg/liter) were high for 6 (3.5%). Quantitative analysis of single-nucleotide polymorphisms showed the TR34/L98H mutation in the cyp51A genes of six isolates. No isolates harboring the TR46/Y121F/T289A mutation were detected. DNA sequencing of the cyp51A gene confirmed the results of the novel endpoint genotyping method. By microsatellite typing, all of the azole-resistant isolates had genotypes different from those previously recovered from Iran and from the Dutch TR34/L98H controls. In conclusion, there was not a significant increase in the prevalence of azole-resistant A. fumigatus isolates harboring the TR34/L98H resistance mechanism among isolates recovered over a recent 5-year period (2010 to 2014) in Iran. A quantitative assay detecting a single-nucleotide polymorphism in the cyp51A gene of A. fumigatus is a reliable tool for the rapid screening and monitoring of TR34/L98H- and TR46/Y121F/T289A-positive isolates and can easily be incorporated into clinical mycology algorithms. Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Related Docs
View other Related Docs
1. Multilocus Variable-Number Tandem-Repeat Analysis of Clinical Isolates of Aspergillus Flavus From Iran Reveals the First Cases of Aspergillus Minisclerotigenes Associated With Human Infection, BMC Infectious Diseases (2014)
2. Multicenter Study of Susceptibility of Aspergillus Species Isolated From Iranian University Hospitals to Seven Antifungal Agents, Microbiology Spectrum (2022)
3. Species Identification and in Vitro Antifungal Susceptibility Testing of Aspergillus Section Nigri Strains Isolated From Otomycosis Patients, Journal de Mycologie Medicale (2018)
4. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex, Mycopathologia (2016)
5. A 9-Year Experience of Aspergillus Infections From Isfahan, Iran, Infection and Drug Resistance (2020)
6. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators Against 354 Molecularly Identified Aspergillus Isolates, Mycopathologia (2020)
7. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)
8. Amino Acid Substitutions in Erg11p of Azole-Resistant Candida Glabrata: Possible Effective Substitutions and Homology Modelling, Journal of Global Antimicrobial Resistance (2016)
Experts (# of related papers)
View all Related Experts
Rasoul Mohammadi (30)
Seyed Hossein Mirhendi Esfahani (22)
Other Related Docs
9. Low Level of Antifungal Resistance in Iranian Isolates of Candida Glabrata Recovered From Blood Samples in a Multicenter Study From 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of Pdr1, Antimicrobial Agents and Chemotherapy (2019)
10. Molecular Epidemiology and Mechanisms of Antimicrobial Resistance in Pseudomonas Aeruginosa Isolates Causing Burn Wound Infection in Iran, Journal of Chemotherapy (2014)
11. Antibiotic Resistance Patterns and Genetic Diversity in Clinical Isolates of Pseudomonas Aeruginosa Isolated From Patients of a Referral Hospital, Isfahan, Iran, Jundishapur Journal of Microbiology (2015)
12. In Vitro Susceptibility Patterns of Clinically Important Trichophyton and Epidermophyton Species Against Nine Antifungal Drugs, Mycoses (2015)
13. Antifungal Activity of Anethum Graveolens Extract and Atrovastatin Against Candida Species Compared to Fluconazole, Journal of Isfahan Medical School (2015)
14. Fatal Disseminated Aspergillosis in an Immunocompetent Patient With Covid-19 Due to Aspergillus Ochraceus, Journal of Medical Mycology (2021)
15. Detection of Erg11 Point Mutations in Iranian Fluconazole-Resistant Candida Albicans Isolates, Current Medical Mycology (2019)
16. Evaluation of Prevalence of New Candida Species (C. Orthopsilosis and C. Metapsilosis) Among C. Parapsilosis Group Isolated From Patients by Pcr-Rflp of Sadh Gene in Iran, Journal of Isfahan Medical School (2011)
17. A Fatal Case of Bloodstream Infection by Fusarium Solani in a Patient With Adrenocortical Carcinoma From Isfahan, Iran, International Journal of Cancer Management (2020)
18. Identification and Frequency of Candida Species in Patients With Different Forms of Candidiasis in Isfahan, Using Pcr-Rflp Method, Journal of Isfahan Medical School (2011)
19. Detection of Opportunistic Fungi From the Bronchoalveolar Lavage Specimens of Patients With Pulmonary Diseases, Advanced Biomedical Research (2023)
20. An Alarming Rise of Non-Albicans Candida Species and Uncommon Yeasts in the Clinical Samples; a Combination of Various Molecular Techniques for Identification of Etiologic Agents, BMC Research Notes (2019)
21. In Vitro Activity of Two Nanoparticles on Clinical Isolates of Candida Parapsilosis, Showing Resistance Against Antifungal Agents in Children, Archives of Clinical Infectious Diseases (2017)
22. In Vitro Activities of Six Antifungal Drugs Against Candida Glabrata Isolates: An Emerging Pathogen, Jundishapur Journal of Microbiology (2016)
23. The Evaluation of the Overexpression of the Erg-11, Mdr-1, Cdr-1, and Cdr-2 Genes in Fluconazole-Resistant Candida Albicans Isolated From Ahvazian Cancer Patients With Oral Candidiasis, Journal of Clinical Laboratory Analysis (2022)
24. In Vitro Antifungal Susceptibility Profile of Iranian Fusarium Isolates: Emphasising on the Potent Inhibitory Effect of Efinaconazole Compared to Other Drugs, Mycoses (2023)
25. Confirmation of Fifth Candida Auris Clade by Whole Genome Sequencing, Emerging Microbes and Infections (2022)
26. Aspergillus Tubingensis and Aspergillus Niger As the Dominant Black Aspergillus, Use of Simple Pcr-Rflp for Preliminary Differentiation, Journal de Mycologie Medicale (2016)
27. Epidemiology and Antifungal Susceptibility of Candida Species Isolated From 10 Tertiary Care Hospitals in Iran, Microbiology Spectrum (2022)
28. Antifungal Activity of Cinnamomum Zeylanicum Essential Oil Against Clinical Isolates of Aspegillus, Journal of Medicinal Plants (2010)
29. Molecular Detection of Candida Spp. and Aspergillus Fumigatus in Bronchoalveolar Lavage Fluid of Patients With Ventilator-Associated Pneumonia, Journal of Research in Medical Sciences (2014)
30. Epidemiologic and Antifungal Susceptibility Profile of Candiduria Among Patients Hospitalized in the Nephrology and Intensive Care Unit Wards, Tehran, Iran, Jundishapur Journal of Microbiology (2022)
31. Utilization of Size Polymorphism in Its1 and Its2 Regions for Identification of Pathogenic Yeast Species, Journal of Medical Microbiology (2017)
32. Direct Detection and Identification of the Most Common Bacteria and Fungi Causing Otitis Externa by a Stepwise Multiplex Pcr, Frontiers in Cellular and Infection Microbiology (2021)
33. Functional Analysis of Two Stat1 Gain-Of-Function Mutations in Two Iranian Families With Autosomal Dominant Chronic Mucocutaneous Candidiasis, Medical Mycology (2021)
34. Frequency of Uncommon Clinical Yeast Species Confirmed by Its-Sequencing, Archives of Clinical Infectious Diseases (2019)
35. Invasive Fusarium Rhinosinusitis in Covid-19 Patients: Report of Three Cases With Successful Management, Frontiers in Cellular and Infection Microbiology (2023)
36. South Asian (Clade I) Candida Auris Meningitis in a Paediatric Patient in Iran With a Review of the Literature, Mycoses (2022)
37. Candida Palmioleophila Candidemia and Bacterial Co-Infection in a 3-Month-Old Infant With Biliary Atresia, Frontiers in Cellular and Infection Microbiology (2023)
38. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated From Clinical Samples, Jundishapur Journal of Microbiology (2017)
39. Regulation of Erg3, Erg6, and Erg11 Genes in Antifungal-Resistant Isolates of Candida Parapsilosis, Iranian Biomedical Journal (2017)
40. Non-Invasive Methods to Diagnose Fungal Infections in Pediatric Patients With Hematologic Disorders, Jundishapur Journal of Microbiology (2016)
41. In-Vivo Efficiency of the Novel Azole Compounds (Attaf-1 and Attaf-2) Against Systemic Candidiasis in a Murine Model, Journal of Medical Mycology (2023)
42. Otomycosis Due to the Rare Fungi Talaromyces Purpurogenus, Naganishia Albida and Filobasidium Magnum, Mycopathologia (2020)
43. In Vitro Antifungal Susceptibility Pattern of Candida Species Isolated From Gastroesophageal Candidiasis, Gastroenterology and Hepatology from Bed to Bench (2021)
44. Molecular Identification of Candida Species Isolated From Gastrooesophageal Candidiasis in Tehran, Iran, Gastroenterology and Hepatology from Bed to Bench (2015)
45. A 3-Year Study of Candida Infections Among Patients With Malignancy: Etiologic Agents and Antifungal Susceptibility Profile, Frontiers in Cellular and Infection Microbiology (2023)
46. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces Glabrata Species Complex: A 5-Year Countrywide Study, Journal of Clinical Laboratory Analysis (2024)
47. Trends in the Prevalence of Amphotericin B-Resistance (Ambr) Among Clinical Isolates of Aspergillus Species, Journal of Medical Mycology (2022)
48. Invasive Fungal Infections in Hematologic Malignancies: Incidence, Management, and Antifungal Therapy, Journal of Research in Medical Sciences (2023)
49. Antifungal Susceptibility Testing of Candida Species Isolated From the Immunocompromised Patients Admitted to Ten University Hospitals in Iran: Comparison of Colonizing and Infecting Isolates, BMC Infectious Diseases (2017)
50. Molecular Strategy for the Direct Detection and Identification of the Most Common Fungal Community in Cerumen Specimens by Multiplex Pcr, Journal of Medical Microbiology (2023)